It has been suggested that PD-L1 is reported to be highly expressed on platelets from cancer patients and is lacking on normal platelets (42–44), which is thought to be the result of PD-L1 transfered from cancer cells to platelets (39). This evidence concerns the gene CD274 and cancer.